Endometriosis is a complex condition affecting millions of women, and diagnosis can take many years. Misdiagnosis is a frequent culprit, often due to overlapping symptoms with other conditions. But there's another layer to this puzzle: a large number of comorbid conditions.

A frequently reported #comorbidity with endometriosis is IBS, irritable bowel syndrome. Overlapping symptoms can cause misdiagnosis and the prescription of medication that may worsen one condition while treating the other.

Other endometriosis comorbidities include autoimmune conditions like lupus and rheumatoid arthritis, and some forms of cancer. Recent studies reveal genetic links between endometriosis and further conditions including chronic pain (migraines, back pain) and inflammatory conditions such as asthma and osteoarthritis.

Sharing information about endometriosis and its comorbidities is crucial. By recognizing the potential for comorbidities, healthcare professionals can provide a more comprehensive diagnosis and develop personalized treatment plans.

Gesynta Pharma is dedicated to the development of better treatments for endometriosis patients, with promising preclinical data for vipoglanstat and a phase II study coming.